A new study conducted by IVI in collaboration with SK bioscience shows that single-dose and two-dose regimens of Vi-DT typhoid conjugate vaccine (TCV) are safe and immunogenic in children 6-23 months of...

Almost seven in 10 Americans would be interested in receiving a COVID-19 vaccine when one becomes available, according to a new study. But researchers say there are concerning gaps in interest, particularly...

Valneva SE, a specialty vaccine company focused on prevention of diseases with major unmet needs, today announced the initiation of a pivotal Phase 3 clinical trial for its differentiated, single-shot...

Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published this week in The Lancet, finding that two formulations of a two-part vaccine have a...

Two recent studies were unable to rule out that H1N1 (“swine flu”) vaccination (“Pandemrix”) and seasonal influenza vaccination given to pregnant women might be associated with...

With COVID-19 vaccine development moving at a rapid pace, the American Medical Association (AMA) is urging the U.S. Food and Drug Administration (FDA) to work more closely with the physician community...

Intravacc, a global leader in translational research and development of viral and bacterial vaccines, has partnered with American, Buffalo, NY, based Therapyx, to further develop and optimize the world’s...

Researchers around the world are racing to find a COVID-19 vaccine to eliminate the need for social distancing, mask wearing, and limits on interpersonal gatherings. In a new study, a computer simulation...

Bavarian Nordic A/S  announced  topline results from the pivotal Phase 3 study of the freeze-dried formulation of its MVA-BN® smallpox vaccine. The Phase 3 lot-consistency study was agreed with the...

Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection...